York profits from Genzyme, Alcon

By Suzy Kenly Waite

Tue Jan 11, 2011

See full 2010 performance information for Jamie Dinan’s 10 funds, which were all positive for the year.

As our recent cover story and 2010 Hedge Fund Report Card noted, everybody loves Jamie Dinan, and it’s not hard to see why. All ten of York Capital Management’s funds were up in 2010, with the largest, the $4.7 billion York Multi-Strategy, returning 7.11% through December. The top performer was the $1.2 billion York Select fund, which was up 16.06% (see the chart below for performance on all York funds). York Multi-Strategy and York Select in December both profited from positions in eye-care company Alcon (the stock was one of York Select’s top five positions that month). In mid-December, Swiss drug maker...

ISSN: 2151-1845 / CDC10004H

Free Trial

Take a trial today and access

  • Performance news, fund launches, regulation changes and people moves
  • Profiles of fund managers, investors and distributors
  • Live league tables
  • Investor mandates

Popular Searches on HFI